Sort
326,823 grants matching “clinical trial”
A Multi-Center Group to Study Acute Liver Failure
$1,976,819William M Lee · Ut Southwestern Medical Center · U01 · FY2011 · DK
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$1,976,695Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CLINICAL PHASE IIB TRIAL OF OXYCYTE PERFLUROCARBON IN SEVERE HUMAN TRAUMATIC BRAIN INJURY
$1,976,684University Of Miami · · FY2008 · Department of Defense
Parkinson's Disease Gene Therapy Study Group
$1,976,669University Of Rochester · U54 · FY2004 · NS
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
$1,976,587James R Cerhan · Mayo Clinic Rochester · U01 · FY2025 · CA
HIV VACCINE TRIAL CLINICAL UNIT
$1,976,524Harvard University (Medical School) · U01 · FY2001 · AI
BIOENGINEERED ANTIBODIES IN CANCER IMAGING AND THERAPY
$1,976,521City Of Hope/Beckman Research Institute · P01 · FY2000 · CA
Mayo Clinic Multiple Myeloma SPORE
$1,976,442Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2023 · CA
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,976,439Julie A. Johnson · University Of Florida · U01 · FY2011 · GM
Biomedical Image Analysis and Informatics
$1,976,426Matthew McAuliffe · Center For Information Technology · ZIA · FY2019 · CT
The Discovering Healthcare Innovations to Address Disparties in Stroke (DIADS) pr
$1,976,099Stephen Sidney · Kaiser Foundation Research Institute · U54 · FY2015 · NS
Comprehensive Sickle Cell Center
$1,975,717Kwaku Ohene-Frempong · Children'S Hosp Of Philadelphia · U54 · FY2006 · HL
Molecular Genetics of Fanconi Anemia
$1,975,695Oregon Health And Science University · P01 · FY2005 · HL
Patient reported outcomes in routine clinical care of patients infected with HIV
$1,975,638Heidi M. Crane · University Of Washington · U01 · FY2012 · AR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$1,975,497S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2010 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$1,975,497S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2010 · RR
Studies in Alzheimer's disease and Neurodegenerative Diseases
$1,975,214Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2018 · AG
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$1,975,209Howland Crosswell · Kiyatec, Inc. · N44 · FY2014 · CA
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
$1,975,189Athan Kuliopulos · Tufts Medical Center · P50 · FY2015 · HL
Psychotherapy Development Research Center
$1,975,101Yale University · P50 · FY2005 · DA
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,975,100Julie A. Johnson · University Of Florida · U01 · FY2014 · GM
The ISCHEMIA Trial - SDCC
$1,975,010Sean M O'Brien · Duke University · U01 · FY2019 · HL
BACE1 as a Therapeutic Target for Alzheimer's Disease
$1,975,000Robert J Vassar · Northwestern University At Chicago · RF1 · FY2019 · AG
Northwestern Cancer Prevention Consortium
$1,974,998Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2020 · CA
Northwestern Cancer Prevention Consortium
$1,974,998Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2021 · CA